Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Primary endometrial carcinoma with signet-ring cells. A case report and review of the literature
1Department of Obstetrics & Gynecology of Miguel Servet University Hospital, 50009, Zaragoza, Spain
2Department of Anatomic Pathology of Miguel Servet University Hospital, 50009, Zaragoza, Spain
DOI: 10.31083/j.ejgo.2020.06.2185 Vol.41,Issue 6,December 2020 pp.879-883
Submitted: 01 July 2020 Accepted: 05 August 2020
Published: 15 December 2020
*Corresponding Author(s): Laura Baquedano Mainar E-mail: lbaquedanome@hotmail.com
Endometrial adenocarcinoma with signet-ring cells is an infrequent histological type of carcinoma that usually corresponds to a metastasis of a primary carcinoma of another origin, mainly from the gastrointestinal tract or the breast. For this reason, in view of this histological finding, it is essential to carry out a thorough evaluation including mammography, gastroscopy, colonoscopy and thoracoab-dominopelvic CT. To date, only six cases of primary endometrial carcinoma with signet-ring cells have been reported in the English literature. A 73-year-old patient was referred to the Gynecology Department with a 3-day history of postmenopausal bleeding. She was diagnosed with primary endometrial adenocarcinoma with signet-ring cells. The anatomopathological special features of the surgical specimen are presented, as well as the evolution of the patient, who remained asymptomatic and free of disease 28 months after surgery. A review of the literature is performed, emphasizing the peculiarities of this rare histological subtype. Despite the fact that primary en-dometrial carcinoma with signet-ring cells is an infrequent tumor, it must be considered in the differential diagnosis of malignant tumors of aforesaid origin. It is essential to carry out a correct and an extensive investigative study as well as an immunohistochemical analysis of the samples obtained for its confirmation diagnosis.
Endometrial adenocarcinoma; Signet-ring cells; Immunohistochemical analysis.
Javier Navarro Sierra, Andrea Espiau Romera, Marta Narváez Salazar, María Jesús Puente Luján, Beatriz Eizaguirre Zarza, Laura Baquedano Mainar. Primary endometrial carcinoma with signet-ring cells. A case report and review of the literature. European Journal of Gynaecological Oncology. 2020; 41(6): 879-883. doi: 10.31083/j.ejgo.2020.06.2185
[1] Akkalp A.K., Ozyurek E.S., Tetikkurt U.S., Yalcin S., Koy Y., Usta A. T.: “Pimary endometrial adenocarcinoma with signet-ring cells: A rarely observed case and review of the literature”. Case Rep. Obstet. Gyneco., 2015, 2015, 404692.
[2] Kurman R.J., Carcangiu M.L., Herrington C.S., Young R.H.: “WHO classification of tumours of female reproductive organs”. 4th Edition, 2014.
[3] Mooney E.E., Robboy S.J., Hammond C.B., Berchuck A., Bentley R. C.: “Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasis”. Int. J. Gynecol. Pathol., 1997, 16, 169-172.
[4] Chebib I., Chu P., Duggan M.A., DiFrancesco L.M.: “Primary signet-ring cell adenocarcinoma of the endometrium: Case report and review of the literature”. Int. J. Gynecol. Pathol., 2010, 29, 269-272.
[5] Boyd C., Cameron I., McCluggage W.G.: “Endometrial adenocar-cinoma with signet ring cells”. Int. J. Gynecol. Pathol., 2010, 29, 579- 582.
[6] Pusiol T.: “HPV11 Positive endometrioid carcinoma of the en-dometrium with signet-ring cells: diagnostic criteria and review of the literature”. Case Rep. Pathol., 2014, 2014, 1-6.
[7] Gown A.M., Fulton R.S., Kandalaft P.L.: “Markers of metastasic carcinoma of breast origin”. Histopathology, 2016, 68, 86-95.
[8] Laury A.R., Perets R., Piao H., Krane J.F., Barletta J.A., French C., et al.: “A comprehensive analysis of PAX8 expression in human epithelial tumors”. Am. J. Surg. Pathol., 2011, 35, 816-826.
[9] Giordano G., Pizzi S., Berretta R., D’Adda T.: “A new case of pri-mary signet-ring cell carcinoma of the cervix with prominent en-dometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature”. World J. Surg. Oncol., 2012, 10, 7.
[10] Iezzoni J.C., Mills S.E.: “Nonneoplastic endometrial signet-ring cells. Vacuolated decidual cells and stromal histiocytes mimicking adenocarcinoma”. Am. J. Surg. Pathol., 2001, 115, 249-255.
[11] McKenna M., McCluggage W.G.: “Signet ring cells of stromal derivation in the uterine cérvix secondary to cauterisation: report of a previously undescribed phenomenon”. J. Clin. Pathol., 2008, 61, 648-651.
[12] Sociedad Española de ginecología y Obstetricia. Oncoguía SEGO: Cáncer de Endometrio 2016. Progresos de Obstetricia y Ginecología, 2017,60, 274-302.
[13] Pecorelli S.: “FIGO committee on gynecologic oncology. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium”. Int. J. Gynaecol. Obstet., 2009, 105, 103-104.
Top